ATNX News and Press, Athenex Inc. From 12/21/22

Top Tips to Use for Finding Penny Stocks to Buy Identifying penny stocks with high potential requires a combination of research, due diligence, and risk management. The key is to look for penny stocks that have strong fundamentals, are trading at a low price, and have the potential to gen...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Rokas Tenys / Shutterstock.com Tesla (NASDAQ: TSLA ) stock price predictions continue to be a concern among investors following Elon Musk’s acquisition of Twitter in October. Tesla stock has been on...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: George Melin/Shutterstock.com Dogecoin ( DOGE-USD ) price predictions are a hot topic among crypto traders on Tuesday as they react to the value of Coinbase (NASDAQ: COIN ). The big news here is Coin...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: shutterstock.com/Champhei Athenex (NASDAQ: ATNX ) stock is rocketing higher on Tuesday thanks to positive results from a high-risk early-stage breast cancer clinical trial. The Phase 2 study covers the u...

Athenex ( NASDAQ: ATNX ) stock has more than doubled premarket after the company posted positive result from its oral drug, paclitaxel plus encequidar in combination with a PD-1 inhibitor and carboplatin to treat in neoadjuvant breast cancer. The company said its oral pac...

BUFFALO, N.Y., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions announced that collaborators at the Quantum Leap ...

BUFFALO, N.Y., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced the exit of its 503B sterile comp...

Shareholders voted in favor of all three proposals submitted before the Special Stockholder Meeting BUFFALO, N.Y., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization...

BUFFALO, N.Y., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced the closing of the sale of...

BUFFALO, N.Y., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Athenex (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that management will participate ...